Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway

Background: In thyroid cancers, a reduction in the expression of the sodium/iodide symporter (NIS) is observed concomitant with a diminution in cancer cell differentiation. The β-catenin/LEF-1 pathway emerges as a crucial regulatory pathway influencing the functional expression of NIS in human thyro...

Full description

Bibliographic Details
Main Authors: Nan-Fang Luo, Jia-Li Li, Juan Lv, Fu-Kun Chen, Ya-Nan Li, Ming Tang, Peng-Jie Liu
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024038714
_version_ 1797224220477882368
author Nan-Fang Luo
Jia-Li Li
Juan Lv
Fu-Kun Chen
Ya-Nan Li
Ming Tang
Peng-Jie Liu
author_facet Nan-Fang Luo
Jia-Li Li
Juan Lv
Fu-Kun Chen
Ya-Nan Li
Ming Tang
Peng-Jie Liu
author_sort Nan-Fang Luo
collection DOAJ
description Background: In thyroid cancers, a reduction in the expression of the sodium/iodide symporter (NIS) is observed concomitant with a diminution in cancer cell differentiation. The β-catenin/LEF-1 pathway emerges as a crucial regulatory pathway influencing the functional expression of NIS in human thyroid cancer cells. Further research is required to comprehensively elucidate the role of NIS overexpression in impeding the progression of thyroid cancer cells. Methods: Human papillary thyroid carcinoma (PTC) cell lines, specifically PTC-1 and KTC-1, were subjected to Scratch and Transwell assays, colony formation, and tumor sphere formation tests to investigate invasion and migration, focusing on the impact of NIS overexpression. The assessment involved the use of western blot to analyze the expression levels of β-catenin, NIS, CD133, SRY-related HMG box2 (Sox2), lymphoid enhancer-binding factor 1 (LEF-1), NANOG, octamer-binding transcription factor 4 (Oct4), aldehyde dehydrogenase 1 family, member A1 (ALDH1A1), and epithelial cellular adhesion molecule (EpCAM). Statistical analysis was conducted using SPSS version 20.0, and the graphs were developed using GraphPad Prism 7 (GraphPad Software, Inc.). Results: Our observations revealed that Nthy-ori-3-1 cell lines exhibited notably higher average expression levels of NIS, yet significantly lower levels of LEF-1 and β-catenin compared to PTC-1 and KTC-1 cell lines. Furthermore, the overexpression of β-catenin resulted in reduced binding of LEF-1 to NIF promotion but concurrently increased the expression of NIS. The downregulation of NIS markedly enhanced the expression of ALDH1A1, CD133, OCT4, Nanog, SOX2, and EpCam—all of which are targets within the Wnt/β-catenin signaling pathway. Conversely, the upregulation of NIS suppressed the expression of these proteins. Moreover, cells treated with β-catenin activators demonstrated an increased capability to form more spheroids and displayed heightened aggressiveness. Conversely, the NIS overexpression (OE) group exhibited suppressed abilities in invasion and colony formation. Conclusion: Thyroid cancer cells exhibit diminished expression of NIS, and the invasion and maintenance of stem cells in thyroid cancer cells were hindered by NIS OE through the inhibition of the β-catenin/LEF-1 pathway. Further research is warranted to comprehensively assess this outcome, which holds promise as a potential targeted treatment for thyroid cancer.
first_indexed 2024-04-24T13:49:39Z
format Article
id doaj.art-bb0b1912aa6c4551a1a0997f72f681ae
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-24T13:49:39Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-bb0b1912aa6c4551a1a0997f72f681ae2024-04-04T05:06:07ZengElsevierHeliyon2405-84402024-03-01106e27840Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathwayNan-Fang Luo0Jia-Li Li1Juan Lv2Fu-Kun Chen3Ya-Nan Li4Ming Tang5Peng-Jie Liu6Department of Cardiac Function, The Cancer Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, ChinaDepartment of Nuclear Medicine, The Cancer Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, ChinaDepartment of Nuclear Medicine, The Cancer Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, ChinaDepartment of Nuclear Medicine, The Cancer Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, ChinaDepartment of Nuclear Medicine, The Cancer Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, ChinaDepartment of Pathology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China; Corresponding author. Department of Pathology The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, No.157 of JinBi Road, Xishan District, Kunming 650032, China.Department of Nuclear Medicine, The Cancer Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, China; Corresponding author. Department of Nuclear Medicine, The Cancer Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, No. 519 of Kunzhou Road, Xishan District, Kunming 650118, China.Background: In thyroid cancers, a reduction in the expression of the sodium/iodide symporter (NIS) is observed concomitant with a diminution in cancer cell differentiation. The β-catenin/LEF-1 pathway emerges as a crucial regulatory pathway influencing the functional expression of NIS in human thyroid cancer cells. Further research is required to comprehensively elucidate the role of NIS overexpression in impeding the progression of thyroid cancer cells. Methods: Human papillary thyroid carcinoma (PTC) cell lines, specifically PTC-1 and KTC-1, were subjected to Scratch and Transwell assays, colony formation, and tumor sphere formation tests to investigate invasion and migration, focusing on the impact of NIS overexpression. The assessment involved the use of western blot to analyze the expression levels of β-catenin, NIS, CD133, SRY-related HMG box2 (Sox2), lymphoid enhancer-binding factor 1 (LEF-1), NANOG, octamer-binding transcription factor 4 (Oct4), aldehyde dehydrogenase 1 family, member A1 (ALDH1A1), and epithelial cellular adhesion molecule (EpCAM). Statistical analysis was conducted using SPSS version 20.0, and the graphs were developed using GraphPad Prism 7 (GraphPad Software, Inc.). Results: Our observations revealed that Nthy-ori-3-1 cell lines exhibited notably higher average expression levels of NIS, yet significantly lower levels of LEF-1 and β-catenin compared to PTC-1 and KTC-1 cell lines. Furthermore, the overexpression of β-catenin resulted in reduced binding of LEF-1 to NIF promotion but concurrently increased the expression of NIS. The downregulation of NIS markedly enhanced the expression of ALDH1A1, CD133, OCT4, Nanog, SOX2, and EpCam—all of which are targets within the Wnt/β-catenin signaling pathway. Conversely, the upregulation of NIS suppressed the expression of these proteins. Moreover, cells treated with β-catenin activators demonstrated an increased capability to form more spheroids and displayed heightened aggressiveness. Conversely, the NIS overexpression (OE) group exhibited suppressed abilities in invasion and colony formation. Conclusion: Thyroid cancer cells exhibit diminished expression of NIS, and the invasion and maintenance of stem cells in thyroid cancer cells were hindered by NIS OE through the inhibition of the β-catenin/LEF-1 pathway. Further research is warranted to comprehensively assess this outcome, which holds promise as a potential targeted treatment for thyroid cancer.http://www.sciencedirect.com/science/article/pii/S2405844024038714β-CateninLEF-1Papillary thyroid carcinomaSodium iodide symporter (NIS)
spellingShingle Nan-Fang Luo
Jia-Li Li
Juan Lv
Fu-Kun Chen
Ya-Nan Li
Ming Tang
Peng-Jie Liu
Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
Heliyon
β-Catenin
LEF-1
Papillary thyroid carcinoma
Sodium iodide symporter (NIS)
title Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
title_full Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
title_fullStr Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
title_full_unstemmed Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
title_short Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
title_sort role of sodium iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β catenin lef 1 pathway
topic β-Catenin
LEF-1
Papillary thyroid carcinoma
Sodium iodide symporter (NIS)
url http://www.sciencedirect.com/science/article/pii/S2405844024038714
work_keys_str_mv AT nanfangluo roleofsodiumiodidesymporteroverexpressionininhibitingthyroidcancercellinvasionandstemcellmaintenancebyinhibitingthebcateninlef1pathway
AT jialili roleofsodiumiodidesymporteroverexpressionininhibitingthyroidcancercellinvasionandstemcellmaintenancebyinhibitingthebcateninlef1pathway
AT juanlv roleofsodiumiodidesymporteroverexpressionininhibitingthyroidcancercellinvasionandstemcellmaintenancebyinhibitingthebcateninlef1pathway
AT fukunchen roleofsodiumiodidesymporteroverexpressionininhibitingthyroidcancercellinvasionandstemcellmaintenancebyinhibitingthebcateninlef1pathway
AT yananli roleofsodiumiodidesymporteroverexpressionininhibitingthyroidcancercellinvasionandstemcellmaintenancebyinhibitingthebcateninlef1pathway
AT mingtang roleofsodiumiodidesymporteroverexpressionininhibitingthyroidcancercellinvasionandstemcellmaintenancebyinhibitingthebcateninlef1pathway
AT pengjieliu roleofsodiumiodidesymporteroverexpressionininhibitingthyroidcancercellinvasionandstemcellmaintenancebyinhibitingthebcateninlef1pathway